timetalk uses cookies to ensure that we give you the best experience on our site. If you continue without changing your browser settings, we'll assume that you are agreeing to our use of cookies. Find out more by reading our cookies policy.
Researchers of a comprehensive new analysis claim that an expensive anti-flu drug bought by the government shows little evidence of success.